EmpowerPharm® a clinical stage pharmaceutical company specializing in cannabinoid-based drug development of prescription products. These products target therapeutic indications where patients need safe and efficacious treatment alternatives to currently available medical options. In addition, EmpowerPharm specializes in the development of novel, solid oral dose formulations for challenging drug molecules demonstrating low aqueous solubility, low bioavailability and high first pass metabolism. Disclosed that their patent – PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF CANNABINOIDS was published today.
Menu